Idexx Laboratories (IDXX) Total Liabilities (2009 - 2026)

Idexx Laboratories has reported Total Liabilities for 18 years, with the latest figure at $1.8 billion in Q2 2026.

• On a quarterly basis, Total Liabilities fell 2.25% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 2.25% decrease from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 2.78% from the prior year.
• Total Liabilities was $1.8 billion for Q2 2026 at Idexx Laboratories, roughly flat from $1.8 billion in the prior quarter.
• The five-year high for Total Liabilities was $2.2 billion in Q3 2022, with the low at $1.7 billion in Q4 2024.
• Average Total Liabilities over 5 years is $1.9 billion, with a median of $1.8 billion recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities soared 32.74% in 2022, then retreated 17.36% in 2023.
• Over 5 years, Total Liabilities stood at $2.1 billion in 2022, then dropped by 16.96% to $1.8 billion in 2023, then fell by 4.35% to $1.7 billion in 2024, then rose by 2.78% to $1.7 billion in 2025, then advanced by 4.83% to $1.8 billion in 2026.
• The last three Total Liabilities figures came in at $1.8 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.7 billion (Q4 2025), per Business Quant data.